UiPath (PATH) Stock Forecast & Price Target

$12.63 -0.90 (-6.65%)

(As of 11/14/2024 ET)

UiPath - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 18 Analyst Ratings

Sell
0

Hold
16

Buy
2

Based on 18 Wall Street analysts who have issued ratings for UiPath in the last 12 months, the stock has a consensus rating of "Hold." Out of the 18 analysts, 16 have given a hold rating, and 2 have given a buy rating for PATH.

Consensus Price Target

$17.47
38.33% Upside

According to the 18 analysts' twelve-month price targets for UiPath, the average price target is $17.47. The highest price target for PATH is $30.00, while the lowest price target for PATH is $12.00. The average price target represents a forecasted upside of 38.33% from the current price of $12.63.

PATH Analyst Ratings Over Time

Type	Current Forecast 11/15/23 to 11/14/24	1 Month Ago 10/16/23 to 10/15/24	3 Months Ago 8/17/23 to 8/16/24	1 Year Ago 11/15/22 to 11/15/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	2 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)	6 Buy rating(s)
Hold	16 Hold rating(s)	16 Hold rating(s)	16 Hold rating(s)	8 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$17.47	$17.71	$18.06	$19.84
Forecasted Upside	38.33% Upside	37.57% Upside	52.40% Upside	6.26% Upside
Consensus Rating	Hold	Hold	Hold	Hold

Central Bank Abandons USD (Ad)

Startling new evidence shows the U.S. Central Bank is abandoning the currency we’ve relied on for centuries – the United States Dollar… And placing a ‘quiet bet’ on a new type of currency… Gold.

Click here now to get your free 'Protect Your Wealth' Guide.

PATH Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

PATH Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

UiPath Stock vs. The Competition

Type	UiPath	Business Services Companies	S&P 500
Consensus Rating Score	2.11	2.68	2.50
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	35.22% Upside	338.44% Upside	8.16% Upside
News Sentiment Rating	Positive News See Recent PATH News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
10/23/2024	JPMorgan Chase & Co. 3 of 5 stars		Lower Target	Overweight ➝ Overweight	$19.00 ➝ $17.00	+42.02%
10/23/2024	Wells Fargo & Company 3 of 5 stars		Lower Target	Equal Weight ➝ Equal Weight	$15.00 ➝ $13.00	+7.44%
10/23/2024	Needham & Company LLC 2 of 5 stars	S. Berg Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Hold
9/6/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Hold ➝ Hold	$17.00 ➝ $16.00	+32.34%
9/6/2024	DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$13.00 ➝ $15.00	+24.07%
9/6/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$14.00 ➝ $15.00	+12.87%
The next assassination attempt won’t be on Trump (Ad) President Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person. I share with you in this special investigative documentary.
9/6/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Sector Perform ➝ Sector Perform	$16.00 ➝ $16.00	+20.39%
9/6/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Equal Weight	$15.00	+12.87%
9/6/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	In-Line ➝ In-Line	$13.00 ➝ $16.00	+25.59%
9/6/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$16.00 ➝ $18.00	+41.29%
9/6/2024	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$14.00 ➝ $15.00	+17.74%
6/3/2024	Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating	F. Havemeyer Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Neutral	$29.00 ➝ $12.00	-2.12%
5/31/2024	Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$30.00 ➝ $19.00	+57.42%
5/30/2024	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$25.00 ➝ $14.00	-23.46%
5/30/2024	William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating	J. Roberge Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
5/30/2024	KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight ➝ Sector Weight
5/30/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Tillman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold	$32.00 ➝ $14.00	-23.46%
5/29/2024	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Sector Perform ➝ Sector Perform	$30.00 ➝ $25.00	+36.17%
3/17/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Outperform	$27.50	+61.29%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 06:31 PM ET.

PATH Forecast - Frequently Asked Questions

: According to the research reports of 18 Wall Street equities research analysts, the average twelve-month stock price forecast for UiPath is $17.47, with a high forecast of $30.00 and a low forecast of $12.00.
: 18 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for UiPath in the last twelve months. There are currently 16 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PATH shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PATH, but not buy additional shares or sell existing shares.
: According to analysts, UiPath's stock has a predicted upside of 38.33% based on their 12-month stock forecasts.
: UiPath has been rated by research analysts at Bank of America, Barclays, BMO Capital Markets, DA Davidson, Evercore ISI, JPMorgan Chase & Co., Morgan Stanley, Needham & Company LLC, Royal Bank of Canada, TD Cowen, and Wells Fargo & Company in the past 90 days.
: Analysts like UiPath less than other "business services" companies. The consensus rating for UiPath is Hold while the average consensus rating for "business services" companies is Moderate Buy. Learn more on how PATH compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

The next assassination attempt won’t be on Trump (Ad)

President Trump is soon to be back in the White House. Unity has been restored to the U.S. But if you watched the President’s 25-minute victory speech, you probably noticed he spent nearly four minutes speaking about one very controversial person.

I share with you in this special investigative documentary.

This page (NYSE:PATH) was last updated on 11/14/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

UiPath (PATH) Stock Forecast & Price Target